Faecal carriage of Pseudomonas aeruginosa in healthy humans: Antimicrobial susceptibility and global genetic lineages

FEMS Microbiology Ecology

Volumn 89, Issue 1, 2014, Pages 15-19

  Estepa, Vanesa ^a   Rojo Bezares, Beatriz ^b   Torres, Carmen ^a,b   Sáenz, Yolanda ^b  

^a UNIVERSITY OF LA RIOJA   (Spain)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

Author keywords

Antimicrobial agents; Integron; MLST; PFGE

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; EPIDEMIC; FECES; GENETIC VARIATION; GENOTYPE; MUTATION; PATHOGEN; PHENOTYPE; POPULATION GENETICS; PUBLIC HEALTH; RELATEDNESS;

PSEUDOMONAS AERUGINOSA;

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIAL GENE; DRUG EFFECT; FECES; FEMALE; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; INTEGRON; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CARRIER STATE; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, PULSED-FIELD; FECES; FEMALE; GENES, BACTERIAL; GENOTYPE; HUMANS; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84903792851     PISSN: 01686496     EISSN: 15746941     Source Type: Journal    
DOI: 10.1111/1574-6941.12301     Document Type: Article

References (19)

1. Cabot G, Ocampo-Sosa AA, Domínguez MA et al. (2012) Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother 56: 6349-6357.
2. Clinical and Laboratory Standards Institute (CLSI) (2013) Performance Standards for Antimicrobial Susceptibility Testing. Twenty-third Informational Supplement (M100-S23). National Committee for Clinical and Laboratory Standards, Wayne, PA.
3. Curran B, Jonas D, Grundmann H, Pitt T & Dowson CG (2004) Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42: 5644-5649.
4. Fernández-Olmos A, García-Castillo M, Alba JM, Morosini MI, Lamas A, Romero B, Galán JC, del Campo R & Cantón R (2013) Population structure and antimicrobial susceptibility of both nonpersistent and persistent Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. J Clin Microbiol 51: 2761-2765.
5. García-Castillo M, del Campo R, Morosini MI, Riera E, Cabot G, Willems R, van Mansfeld R, Oliver A & Cantón R (2011) Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol 49: 2905-2910.
6. Gomila M, Gallegos MC, Fernández-Baca V, Pareja A, Pascual M, Díaz-Antolín P, García-Valdés E & Lalucat J (2013) Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain. BMC Microbiol 13: 138.
7. Kaufmann ME (1998) Pulsed-field gel electrophoresis. Methods Mol Med 15: 17-31.
8. Kerckhoffs AP, Ben-Amor K, Samsom M, van der Rest ME, de Vogel J, Knol J & Akkermans LM (2011) Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol 60: 236-245.
9. Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC & Rainey PB (2012) Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 7: e44199.
10. Lister PD, Wolter DJ & Hanson ND (2009) Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22: 582-610.
11. López-Causapé C, Rojo-Molinero E, Mulet X, Cabot G, Moyà B, Figuerola J, Togores B, Pérez JL & Oliver A (2013) Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. PLoS One 8: e71001.
12. Ocampo-Sosa AA, Cabot G, Rodríguez C et al. (2012) Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob Agents Chemother 56: 1703-1713.
13. Rodríguez-Martínez JM, Poirel L & Nordmann P (2009) Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 4783-4788.
14. Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Seral C, Castillo FJ, Torres C & Sáenz Y (2014) Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. Int J Med Microbiol DOI: 10.1016/j.ijmm.2014.01.001, in press.
15. Ruiz-Martínez L, López-Jiménez L, Fusté E, Vinuesa T, Martínez JP & Viñas M (2011) Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 38: 398-402.
16. Strateva T & Yordanov D (2009) Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-1148.
17. Wiehlmann L, Wagner G, Cramer N et al. (2007) Population structure of Pseudomonas aeruginosa. P Natl Acad Sci USA 104: 8101-8106.
18. Wolter DJ, Hanson ND & Lister PD (2004) Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol Lett 236: 137-143.
19. Woodford N, Turton JF & Livermore DM (2011) Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35: 736-755.